AD Pharma

Global Nonalcoholic Steatohepatitis (NASH) Sales Market 2017 (Weight Loss Treatment, Insulin-Sensitizing Agents, Lipid-Lowering Drugs, Antioxidants and Other Agents) trend, share, size and market players scrutinized in new research

Press Release   •   Feb 23, 2017 10:36 EET

This report studies sales (consumption) of Global Nonalcoholic Steatohepatitis (NASH) Market 2017, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Boehringer Ingelheim?
Cerenis Therapeutics?
Connexios Life Sciences?
Genfit?
Islet Sciences?
Nimbus Therapeutics?
Verva Pharmaceuticals?
Viking Therapeutics?
Astazeneca Plc
Galmed Pharmaceuticals Ltd.
GENFIT SA
Gilead Science
Novo Nordisk
Immuron Ltd
Intercepts Pharmaceuticals
Enzo Biochem, Inc
Tobira Therapeutics, Inc.

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Nonalcoholic Steatohepatitis (NASH) in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India

Request more information at http://globalqyresearch.com/download-sample/173753 

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Weight Loss Treatment
Insulin-Sensitizing Agents
Lipid-Lowering Drugs
Antioxidants
Other Agents

Split by applications, this report focuses on sales, market share and growth rate of Nonalcoholic Steatohepatitis (NASH) in each application, can be divided into
Phase I
Phase II
Phase III
Clinical Trials

View full report at http://globalqyresearch.com/global-nonalcoholic-steatohepatitis-nash-sales-market-report-2017

Table of Contents

Global Nonalcoholic Steatohepatitis (NASH) Sales Market Report 2017
1 Nonalcoholic Steatohepatitis (NASH) Overview
1.1 Product Overview and Scope of Nonalcoholic Steatohepatitis (NASH)
1.2 Classification of Nonalcoholic Steatohepatitis (NASH)
1.2.1 Weight Loss Treatment
1.2.2 Insulin-Sensitizing Agents
1.2.3 Lipid-Lowering Drugs
1.2.4 Antioxidants
1.2.5 Other Agents
1.3 Application of Nonalcoholic Steatohepatitis (NASH)
1.3.1 Phase I
1.3.2 Phase II
1.3.3 Phase III
1.3.4 Clinical Trials
1.4 Nonalcoholic Steatohepatitis (NASH) Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Nonalcoholic Steatohepatitis (NASH) (2012-2022)
1.5.1 Global Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2012-2022)
1.5.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2012-2022)

2 Global Nonalcoholic Steatohepatitis (NASH) Competition by Manufacturers, Type and Application
2.1 Global Nonalcoholic Steatohepatitis (NASH) Market Competition by Manufacturers
2.1.1 Global Nonalcoholic Steatohepatitis (NASH) Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Share by Manufacturers (2012-2017)
2.2 Global Nonalcoholic Steatohepatitis (NASH) (Volume and Value) by Type
2.2.1 Global Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Type (2012-2017)
2.2.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Type (2012-2017)
2.3 Global Nonalcoholic Steatohepatitis (NASH) (Volume and Value) by Regions
2.3.1 Global Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Regions (2012-2017)
2.3.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Regions (2012-2017)
2.4 Global Nonalcoholic Steatohepatitis (NASH) (Volume) by Application

3 United States Nonalcoholic Steatohepatitis (NASH) (Volume, Value and Sales Price)
3.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Value (2012-2017)
3.1.1 United States Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2012-2017)
3.1.2 United States Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2012-2017)
3.1.3 United States Nonalcoholic Steatohepatitis (NASH) Sales Price Trend (2012-2017)
3.2 United States Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Manufacturers
3.3 United States Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Type
3.4 United States Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Application

4 China Nonalcoholic Steatohepatitis (NASH) (Volume, Value and Sales Price)
4.1 China Nonalcoholic Steatohepatitis (NASH) Sales and Value (2012-2017)
4.1.1 China Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2012-2017)
4.1.2 China Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2012-2017)
4.1.3 China Nonalcoholic Steatohepatitis (NASH) Sales Price Trend (2012-2017)
4.2 China Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Manufacturers
4.3 China Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Type
4.4 China Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Application

5 Europe Nonalcoholic Steatohepatitis (NASH) (Volume, Value and Sales Price)
5.1 Europe Nonalcoholic Steatohepatitis (NASH) Sales and Value (2012-2017)
5.1.1 Europe Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2012-2017)
5.1.2 Europe Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2012-2017)
5.1.3 Europe Nonalcoholic Steatohepatitis (NASH) Sales Price Trend (2012-2017)
5.2 Europe Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Manufacturers
5.3 Europe Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Type
5.4 Europe Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Application

6 Japan Nonalcoholic Steatohepatitis (NASH) (Volume, Value and Sales Price)
6.1 Japan Nonalcoholic Steatohepatitis (NASH) Sales and Value (2012-2017)
6.1.1 Japan Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2012-2017)
6.1.2 Japan Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2012-2017)
6.1.3 Japan Nonalcoholic Steatohepatitis (NASH) Sales Price Trend (2012-2017)
6.2 Japan Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Manufacturers
6.3 Japan Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Type
6.4 Japan Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Application
7 Southeast Asia Nonalcoholic Steatohepatitis (NASH) (Volume, Value and Sales Price)
7.1 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales and Value (2012-2017)
7.1.1 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales Price Trend (2012-2017)
7.2 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Manufacturers
7.3 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Type
7.4 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Application
8 India Nonalcoholic Steatohepatitis (NASH) (Volume, Value and Sales Price)
8.1 India Nonalcoholic Steatohepatitis (NASH) Sales and Value (2012-2017)
8.1.1 India Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2012-2017)
8.1.2 India Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2012-2017)
8.1.3 India Nonalcoholic Steatohepatitis (NASH) Sales Price Trend (2012-2017)
8.2 India Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Manufacturers
8.3 India Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Type
8.4 India Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Application

9 Global Nonalcoholic Steatohepatitis (NASH) Manufacturers Analysis
9.1 Boehringer Ingelheim?
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Boehringer Ingelheim? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Cerenis Therapeutics?
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Cerenis Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Connexios Life Sciences?
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Connexios Life Sciences? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Genfit?
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Genfit? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Islet Sciences?
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Islet Sciences? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Nimbus Therapeutics?
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Nimbus Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Verva Pharmaceuticals?
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Verva Pharmaceuticals? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Viking Therapeutics?
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Viking Therapeutics? Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Astazeneca Plc
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Galmed Pharmaceuticals Ltd.
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Galmed Pharmaceuticals Ltd. Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 GENFIT SA
9.12 Gilead Science
9.13 Novo Nordisk
9.14 Immuron Ltd
9.15 Intercepts Pharmaceuticals
9.16 Enzo Biochem, Inc
9.17 Tobira Therapeutics, Inc.

10 Nonalcoholic Steatohepatitis (NASH) Maufacturing Cost Analysis
10.1 Nonalcoholic Steatohepatitis (NASH) Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)
10.3 Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Nonalcoholic Steatohepatitis (NASH) Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast (2017-2022)
14.1 Global Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Nonalcoholic Steatohepatitis (NASH) Price and Trend Forecast (2017-2022)
14.2 Global Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

To Purchase this premium Report With Complete TOC at http://globalqyresearch.com/checkout-form/0/173753

About Us:

Global QYResearch (http://globalqyresearch.com/ ) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Contact: +44 20 32392407

Email: sales@globalqyresearch.com

Follow us:https://www.linkedin.com/company/global-qy-research

Twitter: https://twitter.com/gqyresearch